SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWatkin Jones Regulatory News (WJG)

Share Price Information for Watkin Jones (WJG)

Share Price is delayed by 15 minutes
Get Live Data
19.50    0.00 (0.00%)
Bid:
19.70
Ask:
19.88
Spread: 0.18 (0.914%)
Market Cap: £50.09m
WJG Live PriceLast checked at - London Stock Exchange

Intraday Watkin Jones Share Chart

Confirmation of Board Changes

13 Oct 2021 07:00

RNS Number : 8611O
Watkin Jones plc
13 October 2021
Β 

Β 

Β 

For immediate release

13 October 2021

Β 

Β 

Watkin Jones plc

('Watkin Jones' or the 'Group')

Β 

Confirmation of Board Changes

Β 

Further to the announcement on 19 July 2021, Watkin Jones plc (AIM:WJG) confirms the following changes to its Board of Directors.

Β 

Following an orderly handover, Alan Giddins, Non-executive Director, has assumed the role of Chair and Grenville Turner has retired from the Board, both with effect from 12 October 2021.

Β 

Sarah Sergeant joined the Board on 6 October 2021 as Chief Financial Officer Designate. Phil Byrom, Chief Financial Officer, will step down from the Board after a suitable handover period.

Β 

For further information:

Watkin Jones plc

Β 

Richard Simpson, Chief Executive Officer

Tel: +44 (0) 20 3617 4453

Phil Byrom, Chief Financial Officer

www.watkinjonesplc.com

Β 

Β 

Β 

Peel Hunt LLP (Nominated Adviser & Joint Corporate Broker)

Β 

Tel: +44 (0) 20 7418 8900

Mike Bell / Ed Allsopp

www.peelhunt.com

Β 

Β 

Β 

Jefferies Hoare Govett (Joint Corporate Broker)

Β 

Tel: +44 (0) 20 7029 8000

Max Jones / Will Soutar

Β 

www.jefferies.com

Β 

Β 

Β 

Β 

Media enquiries:

Buchanan

Β 

Henry Harrison-Topham / Richard Oldworth

Jamie Hooper / Steph Whitmore

Β 

Tel: +44 (0) 20 7466 5000

watkinjones@buchanan.uk.com

www.buchanan.uk.com

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCDLLFFFBLFFBQ
Date   Source Headline
1st Jun 20267:00 amRNSChange of Registered Office
28th May 20263:00 pmRNSInvestor Presentation via Investor Meet Company
27th May 20267:00 amRNSHalf Year Results
19th May 20267:00 amRNSNotice of H1-2026 Results
1st May 20267:00 amRNSTotal Voting Rights
29th Apr 20267:00 amRNSHY 2026 Trading Update
13th Apr 20261:50 pmRNSHolding(s) in Company
1st Apr 20267:00 amRNSTotal Voting Rights
25th Mar 20264:20 pmRNSHolding(s) in Company
25th Mar 20264:14 pmRNSHolding(s) in Company
11th Mar 20262:39 pmRNSHolding(s) in Company
27th Feb 20267:00 amRNSDirector/PDMR Shareholding
4th Feb 20262:00 pmRNSResult of AGM
3rd Feb 202611:46 amRNSBlocklisting Application
28th Jan 20261:26 pmRNSHolding(s) in Company
20th Jan 20267:00 amRNSDirector/PDMR Shareholding
6th Jan 20267:00 amRNSAnnual Report and Notice of AGM
22nd Dec 20257:00 amRNSDevelopment Partnership for 294-unit hotel
22nd Dec 20257:00 amRNSDevelopment Partnership for 294-unit hotel
19th Dec 202512:02 pmRNS-RProgressive publishes new research
19th Dec 202512:02 pmRNS-RProgressive publishes new research
17th Dec 20258:17 amRNSPresentation via Investor Meet Company
16th Dec 20257:00 amRNSFull Year Results
15th Dec 20251:10 pmRNSWJ & Maslow Capital announce £102m PBSA scheme
21st Oct 20257:00 amRNSFY25 Trading Update
1st Oct 202510:44 amRNSHolding(s) in Company
30th Sep 20257:00 amRNSWatkin Jones announces £182m PBSA Joint Venture
10th Sep 20257:00 amRNSHolding(s) in Company
5th Sep 20257:00 amRNSAppointment of Joint Corporate Broker
4th Sep 202512:54 pmRNSHolding(s) in Company
12th Aug 20257:00 amRNSDevelopment Partnership for 200-unit PBSA scheme
1st Jul 20257:00 amRNSIssue of Sharesave options and PDMR shareholdings
29th May 20253:36 pmRNSPresentation via Investor Meet Company
29th May 20257:00 amRNSHalf Year Results
28th May 202511:56 amRNSHolding(s) in Company
22nd May 20257:00 amRNSNotice of H1-2025 Results
29th Apr 20257:00 amRNSHY25 Trading Update
4th Apr 20257:00 amRNSDirector/PDMR Shareholding
25th Mar 20257:00 amRNSHolding(s) in Company
4th Mar 20254:12 pmRNSNotification of Major Holdings
4th Mar 20252:26 pmRNSResult of AGM
12th Feb 20252:11 pmRNSNotification of Major Holdings
7th Feb 20257:50 amRNSAnnual Report and Notice of AGM
5th Feb 20257:00 amRNSDirector/PDMR Shareholding
31st Jan 20259:53 amRNSDevelopment Partnership for 260-unit Aparthotel
27th Jan 20254:59 pmRNS-RPresentation via Investor Meet Company
27th Jan 20254:55 pmRNSPresentation via Investor Meet Company
27th Jan 20251:23 pmRNSDirector/PDMR Shareholding
23rd Jan 20257:00 amRNSFull Year Results 2024
17th Jan 20257:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.